The ability to manage and capitalise on opportunities within sustainability can help organisations increase the value of their intangible assets.

Avanos Medical is undervalued with global growth, M&A momentum, and strong cash flow potential driving upside. Learn why AVNS stock is a buy.

Q2 is nearing profitability with strong moats and growth, but overvaluation limits upside despite solid fundamentals. Read ...